GLP-1 drugs reduce psychiatric hospital visits in schizophrenia patients with diabetes
A large US health records study found that people with schizophrenia taking GLP-1 drugs for diabetes had fewer psychiatric relapses and hospital admissions, suggesting potential mental health benefits beyond metabolic effects.
